Table 2. Treatment-related adverse events.
Adverse events | 1–2 grade, n (%) | ≥≥3 grade, n (%) |
---|---|---|
Leucopenia | 3 (15.0) | 1 (5.0) |
Neutropenia | 3 (15.0) | 0 |
Lymphopenia | 2 (10.0) | 0 |
Anemia | 1 (5.0) | 1 (5.0) |
Increased transaminase | 2 (10.0) | 1 (5.0) |
Alopecia | 4 (20.0) | 0 |
Constipation | 2 (10.0) | 0 |
Diarrhea | 1 (5.0) | 0 |
Fatigue | 3 (15.0) | 0 |
Nausea | 4 (20.0) | 0 |
Vomiting | 3 (15.0) | 0 |
Immune dermatitis | 1 (5.0) | 1 (5.0) |
Immune pneumonitis | 0 (0.0) | 0 (0.0) |